Kacso Alex C, Bondor Cosmina I, Coman Anca L, Potra Alina R, Georgescu Carmen E
a University of Medicine and Pharmacy "Iuliu Hatieganu" Cluj , Cluj Napoca ;
b Department of Informatics and Biostatistics , University of Medicine and Pharmacy "Iuliu Hatieganu" Cluj , Cluj Napoca , Romania ;
Scand J Clin Lab Invest. 2016;76(3):217-25. doi: 10.3109/00365513.2015.1137349. Epub 2016 Feb 29.
Visfatin is a proinflammatory molecule with possible actions on glucose metabolism. Interactions to bone metabolism and undercarboxylated osteocalcin (uOC) in diabetic patients (T2DP) with diabetic kidney disease (DKD) have not been reported.
We included 51 incident T2DP with DKD. History, laboratory evaluation, anthropometry, visfatin, uOC were obtained. Fifteen T2DP without DKD were used as controls.
Visfatin was similar in DKD patients and controls: 1.56(0.97-3.03) versus 2.04(1.08-3.21) ng/mL, p = 0.51. In controls, visfatin positively correlated with diabetes duration (r = 0.63, p = 0.01) and negatively with uOC (r = -0.57, p = 0.03). In multivariate regression, diabetes duration remained significant (p = 0.01). In patients with DKD, visfatin was positively linked to C reactive protein (r = 0.27, p = 0.05), tricipital skin fold (TSF) (r = 0.41, p = 0.004) and leukocytes (r = 0.37, p = 0.01); the latter two parameters predicted visfatin in multivariate model (p = 0.001). In normoalbuminuric patients, visfatin was linked to body mass index (r = 0.32, p = 0.04), waist circumference (r = 0.42, p < 0.0001), LDL cholesterol (r = 0.33, p = 0.03), serum glucose (r = 0.36, p = 0.03) and glycated hemoglobin (r = 0.41, p = 0.007); there was a trend towards negative correlation to uOC (r = -0.28, p = 0.07); only glycaemia remained significant in multivariate analysis (p = 0.04). Albuminuric patients displayed a positive correlation of visfatin to waist to hip ratio (r = 0.41, p = 0.04) and leukocytes (r = 0.56, p = 0.04); the latter remained significant in multivariate regression (p = 0.005).
The main determinant of visfatin in T2D patients with DKD is inflammation; in normoalbuminuric patients, a positive link to adiposity and altered glycemic control and a trend towards a negative correlation to uOC was observable; the latter relationship was evident in patients without DKD.
内脂素是一种促炎分子,可能对葡萄糖代谢有影响。糖尿病肾病(DKD)的糖尿病患者(T2DP)中,内脂素与骨代谢及未羧化骨钙素(uOC)之间的相互作用尚未见报道。
我们纳入了51例新发T2DP合并DKD患者。收集病史、实验室评估、人体测量数据、内脂素及uOC数据。15例无DKD的T2DP患者作为对照。
DKD患者和对照组的内脂素水平相似:分别为1.56(0.97 - 3.03)ng/mL和2.04(1.08 - 3.21)ng/mL,p = 0.51。在对照组中,内脂素与糖尿病病程呈正相关(r = 0.63,p = 0.01),与uOC呈负相关(r = -0.57,p = 0.03)。多因素回归分析显示,糖尿病病程仍具有显著性(p = 0.01)。在DKD患者中,内脂素与C反应蛋白(r = 0.27,p = 0.05)、三头肌皮褶厚度(TSF)(r = 0.41,p = 0.004)及白细胞(r = 0.37,p = 0.01)呈正相关;后两个参数在多因素模型中可预测内脂素水平(p = 0.001)。在正常白蛋白尿患者中,内脂素与体重指数(r = 0.32,p = 0.04)、腰围(r = 0.42,p < 0.0001)、低密度脂蛋白胆固醇(r = 0.33,p = 0.03)、血糖(r = 0.36,p = 0.03)及糖化血红蛋白(r = 0.41,p = 0.007)呈正相关;与uOC呈负相关趋势(r = -0.28,p = 0.07);多因素分析中仅血糖仍具有显著性(p = 0.04)。白蛋白尿患者中,内脂素与腰臀比(r = 0.41,p = 0.04)及白细胞(r = 0.56,p = 0.04)呈正相关;后者在多因素回归分析中仍具有显著性(p = 0.005)。
DKD的T2D患者中内脂素的主要决定因素是炎症;在正常白蛋白尿患者中,可观察到内脂素与肥胖及血糖控制改变呈正相关,与uOC呈负相关趋势;后一种关系在无DKD的患者中更为明显。